Replimune Group Inc (NASDAQ: REPL) kicked off on Friday, up 8.95% from the previous trading day, before settling in for the closing price of $5.81. Over the past 52 weeks, REPL has traded in a range of $2.68-$17.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -14.85% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 3.09%. With a float of $64.02 million, this company’s outstanding shares have now reached $77.81 million.
Replimune Group Inc (REPL) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Replimune Group Inc is 17.98%, while institutional ownership is 96.89%. The most recent insider transaction that took place on Aug 15 ’25, was worth 49,157. In this transaction Chief Financial Officer of this company sold 9,154 shares at a rate of $5.37, taking the stock ownership to the 134,368 shares. Before that another transaction happened on May 20 ’25, when Company’s Director sold 32,279 for $8.06, making the entire transaction worth $260,169. This insider now owns 1,405,071 shares in total.
Replimune Group Inc (REPL) Latest Financial update
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.68 earnings per share (EPS), higher than consensus estimate (set at -0.74) by 0.06. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.77 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 3.09% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 22.85% during the next five years compared to -14.85% drop over the previous five years of trading.
Replimune Group Inc (NASDAQ: REPL) Trading Performance Indicators
Take a look at Replimune Group Inc’s (REPL) current performance indicators. Last quarter, stock had a quick ratio of 6.94.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.38, a number that is poised to hit -0.77 in the next quarter and is forecasted to reach -1.75 in one year’s time.
Technical Analysis of Replimune Group Inc (REPL)
Let’s dig in a bit further. During the last 5-days, its volume was 2.93 million. That was inferior than the volume of 3.97 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 73.40%.
During the past 100 days, Replimune Group Inc’s (REPL) raw stochastic average was set at 34.56%, which indicates a significant decrease from 88.03% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.35 in the past 14 days, which was lower than the 0.67 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.10, while its 200-day Moving Average is $10.00. However, in the short run, Replimune Group Inc’s stock first resistance to watch stands at $6.64. Second resistance stands at $6.95. The third major resistance level sits at $7.40. If the price goes on to break the first support level at $5.88, it is likely to go to the next support level at $5.43. The third support level lies at $5.12 if the price breaches the second support level.
Replimune Group Inc (NASDAQ: REPL) Key Stats
The company with the Market Capitalisation of 494.09 million has total of 78,056K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -247,300 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -86,690 K.
